CUPERTINO, Calif. — Apple on Thursday stopped on-line gross sales of two widespread fashions of its internet-connected watch within the U.S. after shedding its newest try and untangle a patent dispute that’s blocking it from utilizing among the expertise on the gadget.

Each the Apple Watch Sequence 9 and Extremely 2 grew to become unavailable to order on-line starting at 3 p.m. ET, as the corporate adopted by way of on its plan to droop gross sales of them due to a authorized battle over an mental property declare filed by medical expertise firm Masimo.

The Worldwide Commerce Fee on rejected Apple‘s bid to get round a late October order blocking the corporate from utilizing a few of expertise underlying the Blood Oxygen measurement characteristic on the Sequence 9 and Extremely 2 watches.

Stymied by the choice, Apple determined to cease to cease promoting the 2 watch fashions within the U.S. to adjust to the ITC ruling that may now stand, except the Biden administration overturns it by Christmas.

Though the net gross sales suspension went into impact Thursday afternoon, the gadgets are scheduled to stay on retailer cabinets till Sunday. The much less refined Apple Watch will stay accessible within the U.S. after Christmas Eve. Beforehand bought Apple Watches geared up with the Blood Oxygen aren’t affected by the ITC order.

Wedbush Securities analyst Dan Ives estimates Apple‘s holiday-season gross sales will likely be decreased by $300 million and $400 million if the patent dispute leads to the 2 watch fashions being pulled from the U.S. market in the course of the closing week of the yr.